Panacea Venture logo

Panacea Venture

Asia, Shanghai, China, Shanghai

Description

Panacea Venture focuses on investing and incubating R&D and innovative companies in the field of life sciences.

Investor Profile

Panacea Venture has made 8 investments, with 1 in the past 12 months and 13% as lead.

Stage Focus

  • Series Unknown (25%)
  • Series C (25%)
  • Series A (25%)
  • Series B (25%)

Country Focus

  • United States (63%)
  • China (38%)

Industry Focus

  • Biotechnology
  • Health Care
  • Biopharma
  • Genetics
  • Health Diagnostics
  • Medical
  • Neuroscience
  • Clinical Trials
  • Pharmaceutical
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Panacea Venture frequently co-invest with?

VC
North America, California, United States, San Diego
Co-Investments: 2
Johnson & Johnson Innovation – JJDC
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
EFung Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
Orient Hontai Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
KTB Network
Asia, Kyonggi-do, South Korea, Seongnam
Co-Investments: 1
Junpu
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
V
North America, California, United States, San Mateo
Co-Investments: 1
HT Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
CDIB Capital
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
Emerging Technology Partners
North America, California, United States, San Francisco
Co-Investments: 2

What are some of recent deals done by Panacea Venture?

Human Longevity

San Diego, California, United States

Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.

BiotechnologyGeneticsHealth CareHealth Diagnostics
Series BAug 21, 2024
Amount Raised: $39,800,000
JADE Biomedical

Suzhou, Jiangsu, China

JADE Biomedical provides biopharmaceutical CMC services.

BiopharmaBiotechnologyEventsTherapeutics
Series BSep 15, 2022
Harvest Integrated Research Organization

Excelsior, Minnesota, United States

Harvest Integrated Research Organization (HiRO) is a globally oriented, innovative clinical research organization (CRO).

BiopharmaBiotechnologyClinical TrialsMedicalPharmaceutical
Series AMar 18, 2022
Amount Raised: $1,572,030
St Phi Therapeutics

Shanghai, Shanghai, China

Yizun Biotechnology is a cutting-edge immune cell therapy company that has developed many unique platform technologies.

BiotechnologyHospitalMedical
Series AJan 11, 2022
TriArm Therapeutics

Beijing, Beijing, China

TriArm Therapeutics is a developer of cellular immunotherapy products intended for the treatment of cancer patients.

BiotechnologyHealth Care
Series UnknownSep 27, 2021
Amount Raised: $60,000,000
XWPharma

Redwood City, California, United States

XWPharma is a neuroscience biotech company that is researching new medicines for sleep, neuropsychiatric, and other neglected CNS illnesses.

BiopharmaBiotechnologyNeuroscience
Series CSep 17, 2020
Amount Raised: $40,000,000
Human Longevity

San Diego, California, United States

Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.

BiotechnologyGeneticsHealth CareHealth Diagnostics
Series CNov 7, 2019
Amount Raised: $30,000,000
BioGraph 55

San Francisco, California, United States

BioGraph 55 is an immuno-oncology target discovery and drug development company.

BiotechnologyOncology
Series UnknownJan 1, 2018